Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 594 clinical trials
Investigation of 2X-121 in Patients With Advanced Ovarian Cancer Selected by the 2X-121 DRP

This study is to be performed as an open label, multicenter, single arm study of 2X-121 to evaluate anti-tumor efficacy of 2X-121 as single agent therapy in a 28-days cycle in advanced ovarian

  • 0 views
  • 26 Jan, 2021
Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Investigational agent, AZD6738 will be given in combination with Olaparib to women with recurrent ovarian cancer (platinum-sensitive or platinum-resistant). This study will determine if

  • 49 views
  • 05 Feb, 2021
  • 4 locations
  • 0 views
  • 14 Feb, 2021
  • 1 location
  • 0 views
  • 28 Jan, 2021
  • 1 location
  • 0 views
  • 29 Jan, 2021
  • 7 locations
Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer

At present, the standard treatment for platinum-resistant ovarian cancer patients is platinum-free chemotherapy, with poor efficacy and tolerance. The combination of anti-angiogenic drugs and

  • 0 views
  • 27 Jan, 2021
  • 1 location
The IPLA-OVCA Trial Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

Surgery and chemotherapy combined constitute first line treatment in women with advanced ovarian cancer. The aim of surgery apart from staging is cytoreduction, i.e. surgical resection of tumour

cytoreductive surgery
metastasis
ovarian cancer stage
surgery for ovarian cancer
cancer of the ovary
  • 0 views
  • 30 Jan, 2021
  • 1 location
Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

The aim of this study is to explore the effectiveness and safety of camrelizumab combined with apatinib mesylate in the treatment of relapsed platinum-resistant epithelial ovarian cancer

  • 0 views
  • 25 Jan, 2021
  • 1 location
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer

epithelial ovarian cancer (EOC), fallopian tube, or primary peritoneal cancer, regardless of platinum sensitivity. Population studied will be female participants experiencing a 1st, 2nd, or 3rd

peritoneal cancer
monoclonal antibodies
metastasis
primary peritoneal carcinoma
platelet count
  • 113 views
  • 25 Jan, 2021
  • 3 locations
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

ovarian cancer/fallopian tube/peritoneal cancer were enrolled in this study. The subjects will be randomly assigned to one of the two treatment groups at a 1: 1 ratio, and the stratification factors

  • 0 views
  • 24 Jan, 2021
  • 1 location